Bridging Strategies to Allogeneic Transplant for Older AML Patients

Treatment options for older patients with intermediate or high-risk acute myeloid leukemia (AML) remain unsatisfactory. Allogeneic stem cell transplantation, the treatment of choice for the majority of younger AML patients, has been hampered in elderly patients by higher treatment related mortality,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecker, Judith, Miller, Isabella, Götze, Katharina S., Verbeek, Mareike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071045/
https://www.ncbi.nlm.nih.gov/pubmed/29997333
http://dx.doi.org/10.3390/cancers10070232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071045/
https://www.ncbi.nlm.nih.gov/pubmed/29997333
http://dx.doi.org/10.3390/cancers10070232

Ejemplares similares